D-0913-2023 Class II Terminated

Recalled by Teva Pharmaceuticals USA Inc — Parsippany, NJ

FDA drug recall D-0913-2023 was initiated by Teva Pharmaceuticals USA Inc on Jul 5, 2023 and is designated Class II. Reason for recall: Failed Moisture Limits: Water (moisture) content above the approved product specifications. The recall status is terminated (terminated Jan 10, 2024). Affected quantity: 180 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 19, 2023
Initiation Date
Jul 5, 2023
Termination Date
Jan 10, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
180 bottles

Product description

Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0093-8199-28

Reason for recall

Failed Moisture Limits: Water (moisture) content above the approved product specifications.

Distribution pattern

Product was distributed to 3 wholesalers/distributors who further distributed the product Nationwide in the USA.

Code information

Lot # 100037220, Exp 10/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0913-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0913-2023. Report a data issue: hello@regdatalab.com.